Abstract
In the present study, the removal of valsartan (VLS), an antihypertensive agent, under simulated solar radiation with the use of molybdenum sulfide-bismuth oxychloride composites (MoS2/BiOCl), of variable MoS2 content (0.1–10.0 wt.%) was investigated. The physicochemical properties of the photocatalysts were examined by XRD, DRS, BET and TEM/HRTEM. Preliminary tests were conducted to examine the photocatalytic efficiency of the synthesized MoS2/BiOCl composites towards VLS degradation in ultrapure water (UPW). It was found that the activity of pure BiOCl is improved with the addition of MoS2. The degradation rate was maximized with the use of the catalyst containing 0.25 wt.% MoS2. It was also found that the increase in catalyst concentration (50–1000 mg/L) enhances VLS degradation. It was found that VLS removal decreased by increasing VLS concentration. The effect of the water matrix on VLS removal was studied by carrying out experiments in real and synthetic water matrices. VLS degradation in UPW was faster than in bottled water (BW) and wastewater (WW), mainly due to the existence of organic matter in real aqueous media. Lastly, 0.25 wt.% MoS2/BiOCl showed great stability after 360 min of irradiation, serving as a promising catalyst for water remediation of emerging contaminants under solar irradiation.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
